Work

Nivolumab and ISA 101 HPV vaccine in incurable HPV-16+ cancer

Year: 2017

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx376.002

Authors: B. Glisson, E. Massarelli, W.N. William, F.M. Johnson, M.S. Kies, R. Ferrarotto, M. Guo, S.A. Peng, J.J. Lee, H. Tran, Y.U. Kim, C. Haymaker, C. Bernatchez, M. Curran, B. Sanchez Espiridion, J. Rodriguez Canales, I.I. Wistuba, S. van der Burg, J. Wang, C. Melief

Institutions: The University of Texas MD Anderson Cancer Center, City Of Hope National Medical Center, City of Hope, Leiden University Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2764009233

FWCI: 1.401

Cites:

Cited by: 23

Related to: 10